STS/AmSECT: Pay No Attention to the Perfusionist Behind the Curtain
All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.
Moderators
Mark Martin, CCP
J.W. Awori Hayanga, MD, MPH, FACS
Panelists
Percy Boateng, MD
Amanda Rhee, MD, MS
Jillian Holler, MS, CCP
Presentations
- Goal-Directed Perfusion & Acute Kidney Injury
David C. Fitzgerald, DHA,MPH,CCP
- Goal-Directed Perfusion & Acute Kidney Injury: Case #1 - Oxygen Delivery and AKI
Cory M. Alwardt, PhD, CCP
Disclosure(s): LivaNova: Consultant (Terminated, June 8, 2023)
- Panel Discussion
- Multidisciplinary OR Crisis Management: Case #2 - Arrest Upon Induction
Jillian Holler, MS, CCP
- Panel Discussion
- Multidisciplinary OR Crisis Management: Case #3 - Cold Antibodies
Gaetano Paone, MD
Disclosure(s): Medtronic LLC: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
- Panel Discussion
Available Credit
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Participation
Price
Cost:
$0.00
All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.
Moderators
Mark Martin, CCP
J.W. Awori Hayanga, MD, MPH, FACS
Panelists
Percy Boateng, MD
Amanda Rhee, MD, MS
Jillian Holler, MS, CCP
Presentations
- Goal-Directed Perfusion & Acute Kidney Injury
David C. Fitzgerald, DHA,MPH,CCP
- Goal-Directed Perfusion & Acute Kidney Injury: Case #1 - Oxygen Delivery and AKI
Cory M. Alwardt, PhD, CCP
Disclosure(s): LivaNova: Consultant (Terminated, June 8, 2023)
- Panel Discussion
- Multidisciplinary OR Crisis Management: Case #2 - Arrest Upon Induction
Jillian Holler, MS, CCP
- Panel Discussion
- Multidisciplinary OR Crisis Management: Case #3 - Cold Antibodies
Gaetano Paone, MD
Disclosure(s): Medtronic LLC: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
- Panel Discussion